Earnings History Data for Ikena Oncology, Inc. (IKNA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Ikena Oncology, Inc.

Ikena Oncology Inc. is focused on developing cancer therapies targeting key signaling pathways which drive the formation and spread of cancer. The company's product candidates include IK-930, IK-175, IK-412 and IK-007, which are in clinical stage. Ikena Oncology Inc. is based in Boston, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
09-11-2023	PM		IKNA	Ikena Oncology	174.00	-0.40	-0.44	0.00		1.33	-2.80 (-67.80%)	3.82	-0.31 (-7.51%)	1.02 - 7.64	3,350,279	60,000	3,192
Ikena tumbles after early data for lead asset, Q3 financials [11/9/2023 12:18 PM]
15-05-2023	PM	8:05 AM ET (May 15)	IKNA	Ikena Oncology	263.00	-0.39	-0.46	0.00	Ikena Oncology GAAP EPS of -$0.39 beats by $0.08, revenue of $5.3M beats by $0.68M [5/15/2023 12:26 PM]	6.96	-0.04 (-0.50%)	6.70	-0.30 (-4.29%)	1.94 - 7.64	62,063	100,000	5,797
Ikena Oncology prices $40M offering [5/15/2023 10:19 AM] Ikena Oncology prices $40M offering [5/15/2023 10:18 AM] Ikena Oncology GAAP EPS of -$0.39 beats by $0.08, revenue of $5.3M beats by $0.68M [5/15/2023 12:26 PM]
14-03-2023	PM		IKNA	Ikena Oncology	164.00	-0.39	-0.53	0.00	Ikena Oncology GAAP EPS of -$0.39 misses by $0.25, revenue of $5.45M misses by $14.51M [3/14/2023 7:51 AM]	4.30	0.08 (1.90%)	0.0	0.0 (0.00%)	1.94 - 8.99	24,429	60,000	0
Ikena Oncology GAAP EPS of -$0.39 misses by $0.25, revenue of $5.45M misses by $14.51M [3/14/2023 7:51 AM]
07-11-2022	PM		IKNA	Ikena Oncology	94.00	-0.48	-0.50	0.00	Ikena Oncology GAAP EPS of -$0.48 beats by $0.01, revenue of $6.4M beats by $2.08M [11/7/2022 8:28 AM]	2.29	0.02 (0.88%)	2.32	0.05 (2.20%)	2.25 - 17.50	123,395	70,000	551
Ikena Oncology GAAP EPS of -$0.48 beats by $0.01, revenue of $6.4M beats by $2.08M [11/7/2022 8:28 AM] Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update [Nov-07-22 08:05AM]
17-03-2022	PM		IKNA	Ikena Oncology, Inc.	201.44	0.07	-0.52	0.00	Ikena Oncology GAAP EPS of $0.08 beats by $0.59, revenue of $20.21M beats by $15.42M [3/17/2022 9:14 AM]	7.77	1.46 (23.14%)	6.36	0.05 (0.79%)	5.31 - 37.61	101,316	133,270	4,265
Ikena Oncology GAAP EPS of $0.08 beats by $0.59, revenue of $20.21M beats by $15.42M [3/17/2022 9:14 AM] Ikena Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Corporate Update [Mar-17-22 07:00AM]
10-11-2021	PM		IKNA	Ikena Oncology	541.00	-0.40	-0.41	0.00	Ikena Oncology EPS beats by $0.02, misses on revenue [11/10/2021 9:08 AM]	16.57	1.49 (9.88%)	0.0	0.0 (0.00%)	9.63 - 37.61	114,768	120,000	0
Ikena Oncology EPS beats by $0.02, misses on revenue [11/10/2021 9:08 AM] Ikena Oncology Reports Third Quarter 2021 Financial Results and Corporate Update [Nov-10-21 07:00AM]